BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: D'souza S, Lau KCK, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26(38): 5759-5783 [PMID: 33132633 DOI: 10.3748/wjg.v26.i38.5759]
URL: https://www.wjgnet.com/1948-5182/full/v26/i38/5759.htm
Number Citing Articles
1
Amanda Jean Craig, Xin Wei Wang. Hepatitis B Virus and Liver Disease2021; : 123 doi: 10.1007/978-981-16-3615-8_6
2
Juris Jansons, Dace Skrastina, Alisa Kurlanda, Stefan Petkov, Darya Avdoshina, Yulia Kuzmenko, Olga Krotova, Olga Trofimova, Ilya Gordeychuk, Irina Sominskaya, Maria Isaguliants. Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV-Related Liver CancerMicroorganisms 2021; 9(5): 1073 doi: 10.3390/microorganisms9051073
3
Yu Jiang, Qiuju Han, Huajun Zhao, Jian Zhang. The Mechanisms of HBV-Induced Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2021; : 435 doi: 10.2147/JHC.S307962
4
Enhua Shen, Jingzhi Zhang, Yujuan Lu. DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23)Bioengineered 2022; 13(1): 1103 doi: 10.1080/21655979.2021.2017629
5
Vaia Valiakou, Petros Eliadis, Eirini Karamichali, Ourania Tsitsilonis, John Koskinas, Urania Georgopoulou, Pelagia Foka. Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and TreatmentInternational Journal of Molecular Sciences 2021; 22(15): 7961 doi: 10.3390/ijms22157961
6
James Lok, Kosh Agarwal. Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An UpdateViruses 2021; 13(7): 1333 doi: 10.3390/v13071333
7
Saleh A. Alqahtani, Massimo Colombo. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular CarcinomaCells 2021; 10(11): 3091 doi: 10.3390/cells10113091
8
Mara Klöhn, Jil Alexandra Schrader, Yannick Brüggemann, Daniel Todt, Eike Steinmann. Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular CarcinomaCancers 2021; 13(22): 5867 doi: 10.3390/cancers13225867
9
Samira Dziri, Christophe Rodriguez, Athenaïs Gerber, Ségolène Brichler, Chakib Alloui, Dominique Roulot, Paul Dény, Jean Michel Pawlotsky, Emmanuel Gordien, Frédéric Le Gal. Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV GenotypeViruses 2021; 13(8): 1572 doi: 10.3390/v13081572
10
Xubo Huang, Joseph T. Glessner, Jinxia Huang, Desheng Zhou, Michael E. March, Hongna Wang, Qianghua Xia, Hakon Hakonarson, Jin Li. Discovery of Novel Host Molecular Factors Underlying HBV/HCV InfectionFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.690882
11
Alessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, Monica Cucco, Giulio V Dalla Riva, Edoardo G Giannini, Fabio Piscaglia, Gianludovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Filomena Morisco, Antonio Gasbarrini, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Filippo Oliveri, Filippo Pelizzaro, Rafael Ramirez Morales, Umberto Cillo, Franco Trevisani, Luca Miele, Giulio Marchesini, Fabio Farinati. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA databaseGut 2021; : gutjnl-2021-324915 doi: 10.1136/gutjnl-2021-324915
12
EV Khorkova, LV Lyalina, OM Mikailova, AYu Kovelenov, YuV Ostankova, DE Valutite, TA Stasishkis, VV Tsvetkov, KE Novak, OYu Rishnyak, IV Kritskaya, LV Buts, DS Tyagunov. Current Issues of Epidemiological Surveillance of Chronic Viral Hepatitis B, C, D and Hepatocellular Carcinoma at the Regional LevelЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2021; : 76 doi: 10.35627/2219-5238/2021-29-8-76-84
13
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma DevelopmentCancers 2021; 13(10): 2485 doi: 10.3390/cancers13102485
14
Bao-Kang Wu, Qian-Hui Chen, Dan Pan, Bing Chang, Li-Xuan Sang. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancerInternational Immunopharmacology 2021; 96: 107790 doi: 10.1016/j.intimp.2021.107790
15
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Ragesh B Thandassery, Emmanouil Giorgakis. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancementsWorld Journal of Gastroenterology 2021; 27(24): 3466-3482 doi: 10.3748/wjg.v27.i24.3466
16
Edward R. Cachay, Colleen Hadigan, Wm. Christopher Mathews. Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevailAIDS 2021; 35(13): 2211 doi: 10.1097/QAD.0000000000003022
17
Kai Zhang, Anna E. Barry, Ryan Lamm, Keyur Patel, Michelle Schafer, Hien Dang. The role of RNA binding proteins in hepatocellular carcinomaAdvanced Drug Delivery Reviews 2022; : 114114 doi: 10.1016/j.addr.2022.114114
18
Marwa Ahmed Sakr, Khaled Abdel Hamid Mohamed, Ahmed Mohamed Hussein, Mohamed Hassan Fouad, Ahmed Samir Allam, Eslam Safwat. Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapyEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00090-y
19
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An updateWorld Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
20
Juliet A. Shenge, Carla Osiowy. Rapid Diagnostics for Hepatitis B and C Viruses in Low- and Middle-Income CountriesFrontiers in Virology 2021; 1 doi: 10.3389/fviro.2021.742722
21
Tianfeng Sun, Jing Zhang. ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progressionThe Journal of Biochemistry 2021; 170(5): 663 doi: 10.1093/jb/mvab088
22
Toofan Datfar, Michael Doulberis, Apostolis Papaefthymiou, Ian N. Hines, Giulia Manzini. Viral Hepatitis and Hepatocellular Carcinoma: State of the ArtPathogens 2021; 10(11): 1366 doi: 10.3390/pathogens10111366
23
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practicesExpert Review of Gastroenterology & Hepatology 2021; 15(5): 487 doi: 10.1080/17474124.2021.1900732
24
Chia-Chen Chen, Guiwen Guan, Xuewei Qi, Abudurexiti Abulaiti, Ting Zhang, Jia Liu, Fengmin Lu, Xiangmei Chen. Pacbio Sequencing of PLC/PRF/5 Cell Line and Clearance of HBV Integration Through CRISPR/Cas-9 SystemFrontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.676957
25
Yung-Tsung Li, Hui-Lin Wu, Chun-Jen Liu. Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1International Journal of Molecular Sciences 2021; 22(17): 9380 doi: 10.3390/ijms22179380
26
Mirco Glitscher, Eberhard Hildt, Daniela Bender. Hepatitis B und C: Mechanismen der virusinduzierten Leberpathogenese und TumorentstehungBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2022;  doi: 10.1007/s00103-021-03482-y
27
Luis E. Gomez-Quiroz, Sonia Roman. Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in MexicoAnnals of Hepatology 2022; 27: 100649 doi: 10.1016/j.aohep.2021.100649
28
Héloïse Leroy, Mingyu Han, Marie Woottum, Lucie Bracq, Jérôme Bouchet, Maorong Xie, Serge Benichou. Virus-Mediated Cell-Cell FusionInternational Journal of Molecular Sciences 2020; 21(24): 9644 doi: 10.3390/ijms21249644
29
Elisabeth Digifico, Silvia Balinzo, Cristina Belgiovine. The Dark Side of the Force: When the Immune System Is the Fuel of Tumor OnsetInternational Journal of Molecular Sciences 2021; 22(3): 1224 doi: 10.3390/ijms22031224
30
Yung-Fang Hsiao, Shao-Bin Cheng, Chia-Yu Lai, Hsiao-Tien Liu, Shih-Chien Huang, Yi-Chia Huang. The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular CarcinomaNutrients 2021; 13(11): 4071 doi: 10.3390/nu13114071
31
Pin Zhao, Samiullah Malik, Shaojun Xing. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.677926
32
Xiaolong Tang, Yandong Miao, Jiangtao Wang, Teng Cai, Lixia Yang, Denghai Mi, Po-Hsiang Tsui. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular CarcinomaComputational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/1205029